University Health Network, Toronto: Adenocarcinoma trials

The registry lists 13 Adenocarcinoma studies with University Health Network, Toronto as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 4No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• 68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal TherapyNot yet recruitingNCT07747493Not applicable
• Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy Using SBRT for Prostate Cancer to Reduce Treatment ToxicityNot yet recruitingNCT07515651Phase 2
• Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & EffectivenessRecruitingNCT07339943Not applicable
• Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate CancerRecruitingNCT05328505Not applicable
• Molecular Characteristics of Gastroesophageal Adenocarcinoma (MOCHA): A Prospective Feasibility StudyRecruitingNCT04219137
• A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA MethylationWithdrawnNCT04262388Phase 2
• High Resolution Ultrasound in Pancreatic Ductal AdenocarcinomaActive, not recruitingNCT03820661Not applicable
• A Study of the Use of Irreversible Electroporation in Pancreatic Ductal CancerCompletedNCT03257150Not applicable
• The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal AdenocarcinomaCompletedNCT02812680
• Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRIActive, not recruitingNCT02306538
• A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With AbirateroneCompletedNCT01857908
• Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line ChemotherapyTerminatedNCT01484860Phase 2
• Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes ProstateCompletedNCT00915122Phase 1/2